1. Substances for which a firm commitment of data has been provided:
cefuroxime2. Substances tentatively added on the priority list pending confirmation that data will become available
pirlimycin
amoxycillin
amprolium
apramycin
clorsulon
coumafos
erythromycin
florfenicol
furosemide
nitroxynil
novobiocin
oxyclozanide
oxytocin
piperazine
trimethoprim
ANNEX: Substances on which sponsors are sought
buparvaquone
chlorfenvinphos
homidium
monensin
parvaquone
rafoxanide
salinomycin
sulfatroxazole
triflumuron